Obesity, high blood pressure impacting many U.S. adults ages 55-64
Half of Americans aged 55-64 have high blood pressure – a major risk factor for heart disease and stroke – and two in five are obese, according to Health, United States, 2005, the government’s annual report to the President and Congress on the health of all Americans. The report was prepared by the Centers for Disease Control and Prevention’s (CDC) National Center for Health Statistics from data gathered by state and federal health agencies and through ongoing national surveys.
Health, United States, 2005
Health, United States is an annual report on trends in health statistics. The report consists of two main sections: A chartbook containing text and figures that illustrates major trends in the health of Americans; and a trend tables section that contains 156 detailed data tables. The two main components are supplemented by an executive summary, a highlights section, an extensive appendix and reference section, and an index. Complete Report 9.9 MB more
FDA and CDC issue alert on Menactra meningococcal vaccine and Guillain Barre Syndrome
The Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) are alerting consumers and health care providers to five reports of Guillain Barre Syndrome (GBS) following administration of Meningococcal Conjugate Vaccine A, C, Y, and W135 (trade name Menactra), manufactured by Sanofi Pasteur. It is not known yet whether these cases were caused by the vaccine or are coincidental. FDA and CDC are sharing this information with the public now and actively investigating the situation because of its potentially serious nature. more
Mayo Clinic Cancer Center reports advancements and solutions for quality of life assessments
Mayo Clinic Cancer Center researchers recently published the first series of chapters in a two-part monograph discussing quality of life (QOL) assessment -- best practices, promising techniques and revolutionary applications. The monograph was published in the November-December issue of Current Problems in Cancer, with the second half to follow in early 2006. more
Pramipexole delivered sustained efficacy in clinical trial of patients with Restless Legs Syndrome
Two large, randomised, placebo-controlled studies presented at the inaugural conference of the World Association of Sleep Medicine (WASM; Berlin, Germany) in October demonstrate that pramipexole delivered both short-term and sustained efficacy in patients suffering from Restless Legs Syndrome (RLS)1,2 enrolled in these trials. more
Breakthrough in unravelling the causes of sudden cardiac death in young people
Scientists at the Wales Heart Research Institute, Cardiff University have made a breakthrough in our understanding of the causes of sudden cardiac death (SCD) in young people.
This research has been funded by the British Heart Foundation. more
Alzheimer's disease prevention may be easier than cure
Current hypotheses suggest that it is the accumulation over time of amyloid beta peptide 1–42 (Abeta42) that triggers changes in the brain that lead to cognitive dysfunction in Alzheimer's disease. The reduction of amyloid levels is therefore a major therapeutic objective. Todd Golde and colleagues from the Mayo Clinic Jacksonville report evidence to suggest that prevention of amyloid deposition may be easier than curing established Alzheimer's disease. Their results will appear online on December 8 in advance of print publication in the January 2006 issue of the Journal of Clinical Investigation. more